Biotech News

Certara Reports Third Quarter 2026 Financial Results

Certara (CERT)CertaraEarnings

Certara delivers a solid quarter with double-digit software revenue growth Updates 2026 financial outlook Appoints Grant Peterson Chief Product Officer Company to host conference call and webcast today at 8:30 a.m. ET RADNOR, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Certara, Inc.

Related news

Certara

Model-Informed Drug Development Certara provides biosimulation software and technology-enabled services used throughout drug discovery, clinical development and regulatory review. Its tools help predict how medicines behave in different patients and dosing scenarios. Software Portfolio The company's software includes pharmacokinetic,...

Recent company news

Stock data

Close
10.68 USD
Market cap
874.27M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States